261 related articles for article (PubMed ID: 17561883)
1. Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.
Occhi G; Albiger N; Berlucchi S; Gardiman M; Scanarini M; Scienza R; Fassina A; Mantero F; Scaroni C
J Neuroendocrinol; 2007 Jul; 19(7):552-9. PubMed ID: 17561883
[TBL] [Abstract][Full Text] [Related]
2. [Distribution and expression of peroxisome proliferator activated receptor gamma in human pituitary adenomas].
Ma Y; Xia XW; Su CB; Kong YG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):375-7. PubMed ID: 16900637
[TBL] [Abstract][Full Text] [Related]
3. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
[TBL] [Abstract][Full Text] [Related]
4. [Expression of peroxisome proliferator-activated receptor-gamma in human pituitary adenomas and its correlation to tumor invasiveness].
Huang CX; Hou YH; Zhao JN; Wang YT; Li JJ; Wen L
Ai Zheng; 2008 Jun; 27(6):590-4. PubMed ID: 18570731
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
[TBL] [Abstract][Full Text] [Related]
7. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
8. PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
Emery MN; Leontiou C; Bonner SE; Merulli C; Nanzer AM; Musat M; Galloway M; Powell M; Nikookam K; Korbonits M; Grossman AB
Clin Endocrinol (Oxf); 2006 Sep; 65(3):389-95. PubMed ID: 16918962
[TBL] [Abstract][Full Text] [Related]
9. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
10. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
11. Protein western array analysis in human pituitary tumours: insights and limitations.
Ribeiro-Oliveira A; Franchi G; Kola B; Dalino P; Pinheiro SV; Salahuddin N; Musat M; Góth MI; Czirják S; Hanzély Z; da Silva DA; Paulino E; Grossman AB; Korbonits M
Endocr Relat Cancer; 2008 Dec; 15(4):1099-114. PubMed ID: 18701577
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA.
Winczyk K; Pawlikowski M
Folia Histochem Cytobiol; 2005; 43(3):137-41. PubMed ID: 16201313
[TBL] [Abstract][Full Text] [Related]
13. HESX1 expression in human normal pituitaries and pituitary adenomas.
Mantovani G; Asteria C; Pellegrini C; Bosari S; Alberti L; Bondioni S; Peverelli E; Spada A; Beck-Peccoz P
Mol Cell Endocrinol; 2006 Mar; 247(1-2):135-9. PubMed ID: 16414177
[TBL] [Abstract][Full Text] [Related]
14. Regulation of peroxisome proliferator activated receptor-gamma in rat pituitary.
Nogueiras R; Caminos JE; Gallego R; Raghay K; Bravo S; Tovar S; Pombo C; López M; Tena-Sempere M; García-Caballero T; Diéguez C
J Neuroendocrinol; 2005 May; 17(5):292-7. PubMed ID: 15869564
[TBL] [Abstract][Full Text] [Related]
15. Survivin products in pituitary tumors.
Jankowska A; Wasko R; Waligorska-Stachura J; Andrusiewicz M; Jaskula M; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):1033-7. PubMed ID: 19112393
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of neurogenins and NeuroD1 in human pituitary tumours.
Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML
J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887
[TBL] [Abstract][Full Text] [Related]
17. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
[TBL] [Abstract][Full Text] [Related]
18. The expression of ghrelin in somatotroph and other types of pituitary adenomas.
Wasko R; Jaskula M; Kotwicka M; Andrusiewicz M; Jankowska A; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):929-38. PubMed ID: 19112387
[TBL] [Abstract][Full Text] [Related]
19. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
20. Expression of Rab3, a Ras-related GTP-binding protein, in human nontumorous pituitaries and pituitary adenomas.
Tahara S; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 1999 Jun; 12(6):627-34. PubMed ID: 10392640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
